Despite insufficient data, writing panel will give recommendations for preparation, transfer, and follow-up for youth with ...

Swiss pharmaceutical giant Novartis said Wednesday that it does not plan to enter into the “frenzy” of weight loss drugs.

The weight-loss market is heating up as a number of companies are looking for a way to upend the dominance of market leaders Novo Nordisk ( NVO) and Eli Lilly ( LLY) by introducing GLP-1 pills.

Ahead of a Senate health committee hearing next week with Novo Nordisk CEO Lars Jørgensen, Sen. Bernie Sanders claims he has ...

In an unconventional alliance, North Carolina State Treasurer Dale Folwell, a Republican, spoke on Capitol Hill at a ...

Rhythm Pharmaceuticals (RYTM) stock gains as JMP Securities issues a positive view on the company citing its lead product ...

The current state of weight-loss treatments is about to shift with the forthcoming availability of GLP-1 drugs in the ...

The release of early-stage data on three oral weight loss drug candidates hints at which companies have the strongest hand, ...

At least a dozen experimental weight-loss drugs designed to be taken as pills are working their way through clinical trials, ...

Analyst Evan Seigerman from BMO Capital maintained a Buy rating on Regeneron (REGN – Research Report) and keeping the price target at ...

At the time, Teladoc Health was hailed as the ultimate telemedicine darling; its stock price skyrocketed to nearly $300 per ...

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any breaking news developments ...